In an uncontrolled study published in 2005, administration of CMV-specific hyperimmune globulin to pregnant women with primary CMV infection significantly reduced the rate of intrauterine ...

Snakebites cause hundreds of thousands of deaths and permanent disabilities every year, but the development of effective antivenoms is extremely challenging — not least owing to the ...

Primary cytomegalovirus (CMV) infection during pregnancy carries a risk of congenital infection and possible severe sequelae. There is no established intervention for preventing congenital CMV ...

Monthly infusions of cytomegalovirus hyperimmune globulin for women with primary cytomegalovirus, or CMV, infection during early pregnancy did not lower the incidence of congenital CMV infection ...

The antibody solution tested in the ITAC trial was anti-coronavirus hyperimmune intravenous immunoglobulin, or hIVIG. The antibodies in anti-coronavirus hIVIG came from the liquid portion of blood ...

Administering hyperimmune globulin to pregnant women who tested positive for cytomegalovirus (CMV) did not reduce CMV infections or deaths among their fetuses or newborns, according to a ...

Marketresearch.biz reports that the The Global Hyperimmune Globulins Market size is expected to be worth around USD 4.5 Billion by 2033, from USD 2.5 Billion in 2023, growing at a CAGR of 6.30% during ...

A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to ...

After developing the horse hyperimmune F(ab')2 concentrate, the group carried out challenge tests in hamsters, injecting the substance into the animals. The researchers evaluated the pretreatment ...

The study Previous works on equine hyperimmune sera against SARS-CoV and MERS-CoV had shown positive results for these closely related betacoronaviruses. Another recent study has shown that the ...